Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Serum Levels of Ficolin-3 and Mannose-Binding Lectin in Patients with Leprosy and Their Family Contacts in a Hyperendemic Region in Northeastern Brazil

Oliveira FJFD, Serra MAADO, Santos LHD, et al. MDPI AG. Tropical Medicine and Infectious Disease. 2022; 7 (5) : 71.
Download PDF
Publication

Impacto da COVID-19 em doenças de notificação compulsória no Norte do Brasil

Brito CVB, Formigosa CDAC, Neto OSM. Fundacao Edson Queiroz. Revista Brasileira em Promoção da Saúde. 2022;
Download PDF
Publication

Can Leprosy Reaction States Mimic Symptoms of Fibromyalgia? A Cross-Sectional Analytical Study.

Feitosa M, Santos G, Cerqueira S, et al. Frontiers in medicine. 2022;
Download PDF
Publication

Arginase 1 is a marker of protection against illness in contacts of leprosy patients.

Prata R, Mendes M, Soares V, et al. Scientific reports. 2022; 12 (1) : 7850.
Download PDF
Publication

Cohort Profile: The 100 Million Brazilian Cohort

Barreto ML, Ichihara MY, Pescarini JM, et al. Oxford University Press (OUP). International Journal of Epidemiology. 2021; 51 (2) : e27-e38.
Download PDF
Publication

HANSENÍASE: DETERMINANTES CLÍNICOS E EPIDEMIOLÓGICOS PARA A OCORRÊNCIA DE LESÃO NERVOSA, REAÇÃO E INCAPACIDADE FÍSICA EM PACIENTES DIAGNOSTICADOS NO NORTE DO TOCANTINS

Bandeira TF. Universidade Federal do Tocantins. 2022;
Download PDF
Publication

Gene Expression Profile of Mycobacterium leprae Contribution in the Pathology of Leprosy Neuropathy.

de Souza B, Mendes M, da Silva G, et al. Frontiers in medicine. 2022;
Download PDF
Publication

Spatial distribution pattern of new leprosy cases under 15 years of age and their contacts in Sobral, Ceará, Brazil

Linhares MSC, Kerr LRFS, Kendall C, et al. FapUNIFESP (SciELO). Ciência & Saúde Coletiva. 2022; 27 (4) : 1641-1652.
Download PDF
Publication

Evolução temporal e distribuição espacial da hanseníase em município de baixa endemicidade no estado de São Paulo

Ramos ACV, Martoreli Júnior JF, Berra TZ, et al. FapUNIFESP (SciELO). Epidemiologia e Serviços de Saúde. 2022;
Download PDF
Publication

Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients.

de Oliveira A, Chaves A, Cardoso M, et al. Microbes and infection. 2022;

Pagination

  • Previous page ‹‹
  • Page 71
  • Next page ››
Subscribe to Brazil

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD